Healthcare Companies Counter Investor Worries Over Wegovy Effect

Healthcare companies who profit from treating obese and overweight patients are trying to convince investors that powerful new weight-loss drugs won't shrink their businesses.

Related Keywords

Denmark ,Boston ,Massachusetts ,United States ,New York ,Bengaluru ,Karnataka ,India ,American ,Danish ,William Blair ,Sonali Paul ,Eli Lilly ,Michael Farrell ,David Gaffen ,Kenneth Stein ,Margaret Kaczor Andrew ,Nicholas Anderson ,Manas Mishra ,Jeff Jonas ,Myriam Curet ,Novo Nordisk Wegovy ,Caroline Humer ,Ann Hynes ,Novo Nordisk ,Reuters ,Johnson ,Boston Scientific ,Thornburg International Growth Fund ,Kaczor Andrew ,Intuitive Surgical ,Michael Erman ,Weight Management ,Obesity ,Bese ,Bariatric Surgery Obesity Weight Loss ,Weight Loss ,Surgery ,Practice Management ,Revenue ,Glp 1 Receptor Agonists ,Glucagon Like Peptide 1 Receptor Agonists ,